|
MEF2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.88909995716358E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16739999889148E-08 |
| Normal-vs-Stage2 |
3.759200E-03 |
| Normal-vs-Stage3 |
1.213620E-04 |
| Normal-vs-Stage4 |
4.976300E-03 |
| Stage1-vs-Stage2 |
5.106600E-01 |
| Stage1-vs-Stage3 |
7.324000E-01 |
| Stage1-vs-Stage4 |
5.797800E-01 |
| Stage2-vs-Stage3 |
3.934600E-01 |
| Stage2-vs-Stage4 |
3.010400E-01 |
| Stage3-vs-Stage4 |
7.554400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08959999911562E-08 |
| Normal-vs-AfricanAmerican |
3.79070000000592E-05 |
| Normal-vs-Asian |
1.69986999999372E-05 |
| Caucasian-vs-AfricanAmerican |
6.838400E-01 |
| Caucasian-vs-Asian |
3.193800E-01 |
| AfricanAmerican-vs-Asian |
2.399000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04020000893479E-09 |
| Normal-vs-Female |
1.649650E-04 |
| Male-vs-Female |
1.554800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.61510999999726E-05 |
| Normal-vs-Extreme_Weight |
1.12070000002351E-06 |
| Normal-vs-Obese |
1.70679000000007E-05 |
| Normal-vs-Extreme_Obese |
1.95150999999782E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.908200E-01 |
| Normal_Weight-vs-Obese |
4.416000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.929200E-01 |
| Extreme_Weight-vs-Obese |
6.036200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.092800E-01 |
| Obese-vs-Extreme_Obese |
3.583400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.71889999999575E-05 |
| Normal-vs-Age(41-60Yrs) |
1.838600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.34749988944804E-10 |
| Normal-vs-Age(81-100Yrs) |
4.095400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.157600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.747800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.720800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.099700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.408200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.375400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.0492000002138E-07 |
| Normal-VS-Type2 PRCC |
4.41400005435355E-09 |
| Normal-VS-KIRP CIMP |
1.62589999996854E-06 |
| Normal-VS-Unclassified PRCC |
1.665690E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.054570E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.760200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.753600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.953000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.298400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.070800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.52413670362739E-12 |
| Normal-vs-N1 |
3.55890000000025E-05 |
| Normal-vs-N2 |
2.098600E-03 |
| N0-vs-N1 |
4.959200E-01 |
| N0-vs-N2 |
8.554000E-01 |
| N1-vs-N2 |
8.987000E-01 |
|
|
